MedKoo's collection

Anticancer agents in preclinical studies

This page is being updated on daily basis, please come to visit very often

Code#   ||   Name

401010  ||   A-443654 (AKT inhibitor)

401012  ||   A-674563 (AKT inhibitor)

401018  ||   A-769662 (AMPK activator)

401019  ||   AG-1478 (EGFR inhibitor)

401020  ||   AG-14361 (PARP Inhibitor)

401025  ||   AMP423 (cyanoaziridine-derivative)

401100  ||   AT7867 (AKT inhibitor)

401140  ||    BIX02188 (MEK inhibitor)

401150  ||   BIX02189 (MEK inhibitor)

401155  ||   BMS-794833 (Met and VEGFR inhibitor)

401210  ||   CCT-137690 (pan-Aurora kinase inhibitor)

401212  ||   CCT128930 (AKT inhibitor)

401213  ||   CEP-28122 (Anaplastic Lymphoma Kinase inhibitor)

401214  ||   CH5424802 (ALK inhibitor)

401220  ||   Chrysophanic acid (EGFR/mTOR pathway inhibitor)

401430  ||   Droxinostat (HDAC inhibitor)

401470  ||   GDC-0879 (B-Raf Inhibitor)

401480  ||   GSK-1904529a  (IGF-1R Inhibitor)

401488  ||   GW788388 (TGF-beta inhibitor)

401510  ||   HM30181 (MDR1 inhibitor)

401520  ||   KP372-1 (Akt inhibitor)

401535  ||   LW6 (HIF-1α inhibitor)

401540  ||   LY475776 (P-glycoprotein inhibitors)

401560  ||   Mubritinib (TAK-165)  (EGFR inhibitor)

401562  ||   NVP-BEP800 (BEP800) (Hsp90 inhibitor)

401565  ||   OSI-420 (CP-473420)  ( EGFR inhibitor )

401680  ||   PD098059 (MEK inhibitor; MAP kinase inhibitor)

401705  ||    PHT-427 (Akt inhibitor)

401710  ||   PP-242 (mTOR inhibitor)

401901  ||   SB202580 (MEK inhibitor; MAP kinase inhibitor)

401903  ||   SB-216763 (glycogen synthase kinase-3 (GSK-3) inhibitor)

401910  ||   SB-431542 (TGF-beta receptor inhibitor, ALK inhibitor)

403550  ||   Tubastatin-A  (HDAC6 inhibitor)

404210  ||   U0126 (MEK inhibitor; MAP kinase inhibitor)

405110  ||   WK-X-34 (P-glycoprotein inhibitors)

405150  ||   WYE-354 (mTOR inhibitor)

405550  ||   XR9051 (P-glycoprotein inhibitors)

Contact MedKoo:

Email: sales@medkoo.com

(Keyword; CAS#; MedKoo code#)